Your Health, We Care

Home >Drug List>Vorasidenib>Indications of Vorasidenib

Vorasidenib(LuciVora)

Release date: 2026-10-21 14:03:44     Recommended: 3

Indicated for the treatment of adult and pediatric patients 12 years of age and older with Grade 2 astrocytoma or oligodendroglioma harboring an IDH1 or IDH2 mutation as detected by an FDA-approved